Technical Analysis for ASRT - Assertio Therapeutics, Inc.

Grade Last Price % Change Price Change
grade D 1.24 2.48% 0.03
ASRT closed up 2.48 percent on Friday, January 17, 2020, on approximately normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Down Up Up
Historical ASRT trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Crossed Above 20 DMA Bullish 2.48%
20 DMA Resistance Bearish 8.77%
NR7 Range Contraction 8.77%
Inside Day Range Contraction 8.77%
Wide Bands Range Expansion 8.77%
Oversold Stochastic Weakness 8.77%
20 DMA Resistance Bearish 6.90%
Wide Bands Range Expansion 6.90%
Oversold Stochastic Weakness 6.90%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Assertio Therapeutics, Inc. is a specialty pharmaceutical company. The Company focuses on pain and other central nervous system (CNS) conditions. Its products include NUCYNTA ER (tapentadol extended release tablets), NUCYNTA IR (NUCYNTA) (tapentadol), Gralise (gabapentin), Cambia (diclofenac potassium for oral solution), Xartemis XR and Zipsor (diclofenac potassium). Its NUCYNTA ER (tapentadol extended release tablets) is a product for the management of pain severe enough to require daily long term opioid treatment, including neuropathic pain associated with diabetic peripheral neuropathy (DPN) in adults, and its NUCYNTA (tapentadol) is a product for the management of moderate to severe acute pain in adults. Its Gralise (gabapentin) is a once-daily product for the management of postherpetic neuralgia (PHN). Its Cambia (diclofenac potassium for oral solution) is a product for the acute treatment of migraine attacks.
Pharmaceutical Pain Organ Systems Chemical Compounds Organic Compounds Analgesics Migraine Treatment Of Migraine Diabetic Peripheral Neuropathy Diclofenac Postherpetic Neuralgia

Is ASRT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 5.76
52 Week Low 0.68
Average Volume 2,733,262
200-Day Moving Average 2.25
50-Day Moving Average 0.97
20-Day Moving Average 1.17
10-Day Moving Average 1.14
Average True Range 0.12
ADX 31.09
+DI 34.85
-DI 17.70
Chandelier Exit (Long, 3 ATRs ) 1.34
Chandelier Exit (Short, 3 ATRs ) 1.36
Upper Bollinger Band 1.35
Lower Bollinger Band 1.00
Percent B (%b) 0.69
BandWidth 30.03
MACD Line 0.04
MACD Signal Line 0.05
MACD Histogram -0.0057
Fundamentals Value
Market Cap 78.1 Million
Num Shares 63 Million
EPS -1.79
Price-to-Earnings (P/E) Ratio -0.69
Price-to-Sales 0.75
Price-to-Book 1.50
PEG Ratio 0.46
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.36
Resistance 3 (R3) 1.36 1.31 1.34
Resistance 2 (R2) 1.31 1.28 1.32 1.33
Resistance 1 (R1) 1.28 1.26 1.26 1.28 1.33
Pivot Point 1.23 1.23 1.22 1.24 1.23
Support 1 (S1) 1.20 1.20 1.18 1.20 1.15
Support 2 (S2) 1.15 1.18 1.16 1.15
Support 3 (S3) 1.12 1.15 1.14
Support 4 (S4) 1.12